Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cellsSangya Agarwal, Carl H. June, Mercy Gohil et al.|Immunity|2023Cited by 164
Clinical and molecular dissection of CAR T cell resistance in pancreatic cancerM. Ángela Aznar, Mark H. O’Hara, Charly R. Good et al.|Cell Reports Medicine|2025Cited by 12
Abstract 5571: Disruption of cell-intrinsic checkpoint regulator CTLA-4 in CD19 directed CAR T cells provides clinical efficacy in CLL patientsSangya Agarwal, Carl H. June, Angela Aznar Gomez et al.|Cancer Research|2022Cited by 2